Noselab

Medical Equipment Manufacturing • Munich, Bavaria, Germany • 21-50 Employees

Company overview

Headquarters	Widenmayerstr. 27, München, 80538, DE
Website	noselab.com
NAICS	3391
Keywords	Biopharma, Biobanking, Diagnostics, Clinical Research, Product Development, Medical Device, Data Analysis, Proteomics, Neurodegenerative Diseases, Translational Science, Multi-Modal, Biopharma Services, Neurological Diseases, Ai Driven, Multi-Omics, Data Driven Medicine, Brain-Derived Biomarker, Brain-Nose Interface, Diagnostic Platform
Founded	2020
Employees	21-50

Key Contact at Noselab

Mareike Albert

Founder & Cso

Noselab Email Formats

Noselab uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@noselab.com), used 60% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@noselab.com	60%
{first initial}.{last name}	j.doe@noselab.com	20%
{first initial}.{last name}{last name}	j.doedoe@noselab.com	13.3%
{first initial}	j@noselab.com	6.7%

About Noselab

A window to the brain. Noselab is a pioneering force in diagnostic breakthrough technology, specializing in the early detection and management of brain diseases. The company is developing a groundbreaking, non-invasive, and scalable biomarker platform that enables the detection, measurement, and clinical validation of brain-derived molecular biomarkers in nasal secretion – powered by AI-driven patient profiling and stratification for precision medicine. By leveraging the brain-nose interface (BNI) as a structural and functional gateway to the central nervous system, and supported by multiple independent studies confirming the presence of CNS biomarkers in nasal samples, Noselab is pioneering a novel diagnostic approach in neuroscience. As a member of the Bavarian Biotech cluster, Noselab collaborates with leading experts and institutions to drive innovation and foster collaboration in biomedical research and development. Our vision: Revolutionizing the understanding, diagnosis and treatment of diseases leveraging the brain-nose interface. Our mission: Establish Noselab as a platform for brain-derived biomarkers in nasal secretion. Interested to join our team? Contact us.

Noselab revenue & valuation

Annual revenue	$1,967,765
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$6,300,000
Total funding	No funding

Employees by Management Level

Total employees: 21-50

Seniority

Employees

C-Suite

Entry

Senior

Employees by Department

Noselab has 10 employees across 8 departments.

Departments

Number of employees

Funding Data

Noselab has never raised funding before.

Noselab Tech Stack

Discover the technologies and tools that power Noselab's digital infrastructure, from frameworks to analytics platforms.

Slick

JavaScript libraries

WP Rocket

Caching

PWA

Miscellaneous

jQuery UI

JavaScript libraries

Hello Elementor

WordPress themes

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

Frequently asked questions

Noselab is located in Munich, Bavaria, DE.

Noselab was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Noselab has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Noselab

Mareike Albert

Founder & Cso

4.8

40,000 users